COMPANY

HOPO Therapeutics

HQ: Emeryville, CA source · hopotx.com ↗

Stage (company-reported): Phase 1 · source · Oct 12, 2026

HOPO-101 is being developed in oral dosage forms to enable rapid, widespread deployment, as well as convenient self-administration outside of a hospital or other treatment setting. From company website Source · Oct 13, 2026

Profile checked Oct 10, 2026

Timeline

Oct 28, 2024 Grant Government contract: $226M (up to, as announced), announced Oct 28, 2024. Source: company release on GlobeNewswire. source ↗

Funding

Last 2 years.

Oct 28, 2024 Government contract: $226M (up to, as announced), announced Oct 28, 2024. Source: company release on GlobeNewswire. source ↗